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We examined the importance of application volume and area in the absorption of phenol red 
as a model drug from the rat liver surface, for pharmaceutical formulation concerning 
administration form. 
When 1 mg of phenol red was applied to the rat liver surface in-vivo using a cylindrical 
glass cell (i.d. 9 mm) in three volumes (0.1, 0.2 or 0.334 mL), the shape of the plasma 
concentration pattern differed greatly, particularly the maximum concentration.   These 
patterns were well fitted by a two-compartment model with first-order absorption, and the 
obtained absorption rate constant Ka decreased inversely according to the application volume.   
The absorption ratio and biliary recovery of phenol red at 6 h was increased with glass cell 
area (i.d. 6, 9 or 14 mm; area 0.28, 0.64 or 1.54 cm2).   Furthermore, the permeability 
coefficient Papp derived from Ka did not depend on application area, indicating no difference in 
absorption characteristics of liver surface.   This also implies transport of a drug by a 
passive diffusion from the liver surface. 
After intraperitoneal administration to the rat liver surface for clinical application, 
increase in application volume resulted in the delayed disappearance of phenol red from 
plasma.   However, the difference was not as marked as that using a glass cell.   The 
assumption that the effective area relating to the absorption changed with the application 
volume enabled us to estimate Papp. 
Consequently, we speculate absorbability can be estimated precisely by considering 





Previously (Nishida et al 1994), we reported on drug absorption from the liver surface in rats, 
and demonstrated that direct application to the liver surface is useful for drug delivery to the 
target site in the liver.   Furthermore, we examined the mechanism of drug absorption from 
the liver surface (Nishida et al 1995a,b; 1996), by using several organic anions and FITC-
labeled dextrans of different molecular weights as model drugs. 
An appropriate pharmaceutical modification for enhancement of drug release and 
adhesion with the liver surface should be considered to improve drug targeting to the liver.   
Therefore, application conditions such as volume and area are very important factors in the 
absorption from the liver surface. 
In the present study, we selected phenol red as a model drug, the absorption mechanism 
of which has been already clarified (Nishida et al 1994; 1995a,b), and examined the influence 
of application volume and area of a glass cell on the absorption characteristics from the liver 
surface in rats.   Furthermore, we also studied intraperitoneal administration of phenol red to 






Phenol red was purchased from Nacalai Tesque, Inc. (Kyoto, Japan).   All other chemicals 
were reagent grade products. 
 
In-vivo experiment 
All animal procedures in the present study conformed to the Guideline for Animal 
Experimentation in Nagasaki University. 
Male Wistar rats (230-250 g) were anesthetized with sodium pentobarbitone (50 mg/kg, 
i.p.) and the left femoral artery was cannulated with a polyethylene tube (i.d. 0.5 mm, o.d. 0.8 
mm; Dural Plastics, Dural, Australia).   A 3 cm incision was made in the middle abdomen, 
and the common bile duct was cannulated with a polyethylene tube (i.d. 0.28 mm, o.d. 0.61 
mm; Becton Dickinson & Co., Parsippany, NJ, U.S.A.).   The phenol red solution was 
administered as follows. 
Application to the rat liver surface: A cylindrical glass cell (i.d. 9 mm, effective area 
0.64 cm2) was attached to the rat liver surface at the area of the left lobe with Aron Alpha 
(Sankyo Co. Ltd, Tokyo, Japan).   The body temperature of the rats was kept at 37°C by a 
heat lamp throughout the experiment.   The phenol red solution containing 1 mg was 
prepared in an isotonic phosphate buffer (pH 7.4) to yield a volume of 0.1, 0.2 or 0.334 mL, 
and added to the glass cell directly.   The top of the glass cell was sealed with a piece of 
aluminum foil to prevent evaporation of the applied solution.   In another experiment, 
phenol red was administered to the rat liver surface, by employing a cylindrical glass cell (i.d. 
6 or 14 mm, effective area 0.28 or 1.54 cm2). 
Intraperitoneal (i.p.) administration to the rat liver surface: Phenol red (1 mg) in an 
isotonic phosphate buffer (pH 7.4) at volumes of 0.2, 1 and 5 mL was administered 
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intraperitoneally to the liver surface.   The injection point of i.p. administration was the 
division between the right and left lobe. 
After administration, blood samples (200 µl) were collected at selected times after 
dosing from the heparinized cannula inserted into the femoral artery over a 6-h period and 
centrifuged at 15000 rpm for 5 min.   Bile samples were collected at appropriate time 
intervals for 6 h.   At 6 h after the application, the urine remaining in the bladder was 
collected with a syringe.   In addition, the solution remaining in the glass cell or peritoneal 
cavity was withdrawn. 
 
Analytical method 
The concentrations of phenol red in the plasma, bile, urine and remaining solution in the glass 
cell or peritoneal cavity were determined as follows.   The concentration of free phenol red 
was determined spectrophotometrically at 560 nm after dilution with a 1 M NaOH solution.   
The total concentration of free phenol red and its metabolite was similarly measured after 
subjection to acid hydrolysis (1 M HCl at 100°C for 30 min) (Hart & Schanker 1966). 
 
Compartment model analysis 
First, the plasma concentration (Cp) profile of phenol red after i.v. administration was fitted to 
the biexponential equation described as follows (eq. 1), by the nonlinear least-squares method 





















α β21 21  (1) 
Hybrid parameters α and β are defined as α + β = K12 + K21 + Kel and α·β = K21·Kel.   Vc is 
the volume of the central compartment.   Kel is the first-order elimination rate constant from 
the central compartment.   K12 and K21 are the first-order transfer rate constants between the 
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central and peripheral compartment.   These parameters were substituted into the following 
equation for the plasma concentration after application to the rat liver surface.   The result 
for i.v. administration has been already reported (Nishida et al 1995a). 
   Next, in the same way, the plasma concentration profile of phenol red after 
application to the rat liver surface was fitted in the two-compartment model with first-order 
absorption, by the nonlinear least-squares method (Yamaoka et al 1981).   In this model, the 
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Ka is the first-order absorption rate constant for absorption into the blood stream from the rat 
liver surface or peritoneal cavity.   F is the availability after application to the rat liver 
surface or i.p. administration to around the rat liver surface. 
 
Statistical analysis 
Statistical analysis was performed by applying unpaired Student’s t-test.   p < 0.05 was 
considered to be statistically significant.   All results were expressed as the mean value ± 




Effect of application volume on absorption of phenol red from rat liver surface 
First, the plasma concentrations of phenol red were determined for 6 h after application to the 
rat liver surface at a dose of 1 mg in three volumes (0.1, 0.2 or 0.334 mL) employing a glass 
cell (i.d. 9 mm), as illustrated in Fig. 1.   We observed a marked decrease in maximum 
concentration and a prolongation of plasma concentration, as the application volume 
increased.   The biliary excretion rate patterns of free phenol red and its metabolite showed 
a similar tendency (data not shown). 
Table 1 lists the recovery of phenol red at 6 h in the bile, urine and glass cell after 
application to the rat liver surface at a dose of 1 mg in three volumes.   The recovery ratio in 
the glass cell at 6 h was affected significantly by the application volume.   The extent of 
absorption of phenol red in 6 h was calculated from the recovery ratio to be 91.8, 71.5 and 
46.8 % of dose at volumes of 0.1, 0.2, and 0.334 mL, respectively.   Also, the biliary 
recovery of phenol red in 6 h tended to decrease as the absorption ratio decreased according 
to the application volume. 
Moreover, we tried to examine the effect of application volume, by applying a two-
compartment model with first-order absorption (Nishida et al 1995a, 1996).   As shown in 
Fig. 1, each curve fitted the experimental value, suggesting the validity of the 
pharmacokinetic analysis.   The calculated Ka values listed in Table 1 were inversely 
proportional to the application volume. 
 
Effect of application area on absorption of phenol red from rat liver surface 
Next, we examined the effect of application area of the glass cell on the absorption of phenol 
red from the rat liver surface.   Figures 2a and 2b illustrate the plasma concentration profiles 
of phenol red at a dose of 1 mg (10 mg/mL X 0.1 mL (a) or 3 mg/mL X 0.334 mL (b)) after 
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application to the rat liver surface with three different glass cells (i.d. 6, 9 or 14 mm, effective 
area 0.28, 0.64 or 1.54 cm2).   At 10 mg/mL X 0.1 mL (Fig. 2a), the plasma concentration 
pattern at the large area (0.64 cm2) was sharp and the maximum concentration increased two-
fold, compared to the small area (0.28 cm2).   A similar relationship between the small and 
large glass cells was observed at 3 mg/mL X 0.334 mL, as shown in Fig. 2b.   The biliary 
excretion rate profiles of free phenol red and its metabolite changed with the area of glass cell 
(data not shown). 
Table 2 summarizes the recovery of phenol red at 6 h in the bile, urine and solution 
remaining in the glass cell under several experimental conditions.   At application volumes 
of 0.1 and 0.334 mL, the absorption ratio from the rat liver surface at 6 h increased 
significantly 1.4 and 1.8 times, respectively, with increase in the application area.   A similar 
trend was seen in the biliary recovery ratio of phenol red. 
A good agreement was observed between experimental values and fitting lines (Figs. 2a 
and 2b), and the calculated Ka values are listed in Table 2.   In general, the Ka value 
increased in proportion to the application area, indicating that application area determines the 
absorption rate from the rat liver surface. 
 
Effect of application volume on pharmacokinetics of phenol red after i.p. administration to rat 
liver surface 
For clinical application, we studied the peritoneal absorption of phenol red in different 
application volumes.   Figure 3 shows the plasma concentration profiles of phenol red after 
i.p. administration to the rat liver surface at a dose of 1 mg in three volumes (0.2, 1 or 5 mL).   
The plasma concentration profiles after i.p. administration were delayed by increase in the 
application volume.   However, there was no significant difference in the plasma 
concentration profiles among the three application volumes, irrespective of the large variation 
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(0.2 to 5 mL) relative to that obtained using a glass cell (0.1 to 0.334 mL). 
Table 3 lists the biliary and urinary recovery of phenol red at 6 h after i.p. 
administration to the rat liver surface.   For every application volume, more than 97 % of 
dose was absorbed from the peritoneal cavity in 6 h.   Accordingly, no significant difference 
was seen for the biliary and urinary recovery of phenol red, by alteration in application 
volume (Table 3). 
Moreover, we calculated the Ka value of phenol red by pharmacokinetic analysis of the 
plasma concentration profile, on the assumption of first-order absorption from the peritoneal 
cavity around the liver surface.   In the pharmacokinetic analysis, best-fit curves in the three 
volumes were obtained as shown in Fig. 3, suggesting that this model can explain the 
pharmacokinetics after i.p. administration.   The Ka after i.p. administration to the rat liver 





From the results obtained here, application volume and area appear to be significant factors in 
the application of drug to the liver surface.   The absorption characteristics of drug from the 
liver surface can be precisely evaluated with the clearance concept.   The elimination 
clearance of phenol red from the glass cell, which is assumed to be apparent absorption 
clearance CLa,app (mL/min), is expressed as follows, 
CL K Va app a a, = ⋅  (3) 
where Va is the application volume.   Furthermore, the absorption clearance per application 







where Area means effective application area of a glass cell (cm2).   This parameter (Papp, 
cm/min) is equivalent to the apparent diffusion coefficient, representing drug absorbability 
from the liver surface.   The CLa,app and Papp of phenol red after application to the rat liver 
surface with a glass cell were calculated according to eqs 3 and 4, as summarized in Tables 1 
and 2. 
Although the Ka value decreased with the increase in application volume (Table 1), the 
CLa,app was not affected (about 1 X 10-3 mL/min).   This suggests equal absorbability from 
the liver surface when identical glass cells are used.   Accordingly, the application area 
should be a main determinant of absorption from the liver surface. 
Furthermore, we studied the change in absorption from the liver surface using several 
glass cells with different application areas (0.28, 0.64 and 1.54 cm2).   In general, the 
absorbability of phenol red increased according to the application area judging from CLa,app 
(Table 2).   On the other hand, no significant difference was seen in Papp among the three 
application areas (Table 2), ranging from 1.44 X 10-3 to 1.74 X 10-3 cm/min.   This result 
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indicates that the liver surface membrane is broadly uniform with respect to absorption 
characteristics.   Additionally, we confirmed the simple passive transport of drug across the 
liver surface (Nishida et al 1995a). 
The application to the liver surface for clinical use is expected to be close to follow 
conventional administration into the abdominal cavity.   Previously (Nishida et al 1995c), 
we clarified i.p. administration to the liver surface enhances drug delivery to the liver in rats, 
because the absorption rate of the model drugs from the peritoneal cavity around the liver 
surface was high, as compared with around the small intestine.   I.p. administration has been 
extensively applied to the treatment of cancers restricted to the peritoneal cavity such as 
ovarian carcinoma, and is considered to be an effective method for organ-specific drug 
delivery, owing to ease of regional delivery of anticancer drugs to the target site. 
Recently, several pharmaceutical preparations such as liposome (Allen et al 1992; 
Sharma et al 1996), microsphere (Cremers et al 1994; Hagiwara et al 1996) and carbon 
particle (Hagiwara et al 1988, 1992) have been used for controlled release of drug in 
peritoneal cavity.   For i.p. administration, application volume influences the absorption rate 
of drug considerably (Nagy et al 1989; Barrett et al 1991; Bredberg et al 1994).   However, 
changes in drug absorption from the peritoneal cavity with application volume have not been 
considered relative to alterations in effective absorption area. 
Similar to the application with a glass cell, the plasma concentration patterns of phenol 
red after i.p. administration to the rat liver surface were delayed and prolonged (Fig. 3), as the 
application volume increased.   Obviously, the appearance of phenol red in plasma after i.p. 
administration was much faster than that using a glass cell.   The absorption area is limited 
when the drug is applied with a glass cell, whereas the drug solution administered 
intraperitoneally distributes in the peritoneal cavity around the liver surface, resulting in 
increase of effective absorption area. 
11 
We calculated the apparent absorption clearance CLa,app on the assumption of first-order 
absorption from the peritoneal cavity, by regarding the volume of absorption compartment as 
the applicated one.   However, the derived CLa,app values differed considerably among the 
three volumes, as shown in Table 3.   This result indicates that application area varies with 
application volume for i.p. administration. 
The effective absorption area after i.p. administration is considered to depend on 
application volume, owing to drug diffusion in the peritoneal cavity.   Therefore, we 
assumed that the administered solution exists in the peritoneal cavity as a sphere, in which the 
surface area is minimal.   The surface area of the sphere of the administered volumes 0.2, 1, 
and 5 mL was estimated according to eq. 5 to be 1.7, 4.8 and 14.1 cm2, respectively.   The 
corrected absorption clearance Papp was derived, as listed in Table 3.   The derived Papp values 
were of the same magnitude among the three application volumes (0.45 X 10-2 - 0.61 X 10-2 
















We do not think that the administered drug solution actually exists as a globular shape 
in the peritoneal cavity.   Accordingly , it is necessary to understand the change in 
absorbability caused by dilution of drug solution with the serous fluid, binding of drug to the 
ingredient in peritoneal fluid or adhesion of drug to the peritoneal surrounding organ. 
 
In conclusion, absorption rate from the liver surface appears to correlate with 
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Figure titles and legends 
FIG. 1.  Plasma concentration profiles of phenol red at a dose of 1 mg in three volumes after 
application to rat liver surface.   Curves show simulated functions based on the 
pharmacokinetic parameters shown in Table 1.   Each point represents the mean ± s.e. of 
four experiments. 
 
FIG. 2.  Plasma concentration profiles of phenol red at a dose of 1 mg (10 mg/mL X 0.1 mL 
(a) or 3 mg/mL X 0.334 mL (b)) at three application areas after application to rat liver 
surface.   Curves show simulated functions based on the pharmacokinetic parameters 
shown in Table 2.   Each point represents the mean ± s.e. of four experiments. 
 
FIG. 3.  Plasma concentration profiles of phenol red at a dose of 1 mg in three volumes after 
intraperitoneal administration to rat liver surface.   Curves show simulated functions based 
on the pharmacokinetic parameters shown in Table 3.   Each point represents the mean ± s.e. 





Table 1.  Recovery in 6 h and pharmacokinetic parameters of phenol red at a dose 
of 1 mg in three volumes after application to rat liver surface. 
 
 
 Volume  Recovery (% of dose)  Ka CLa,app Papp
 (mL) Glass cell Bile Urine    
 
 
 0.1 8.2 50.7 29.3 9.20 0.92 1.44 
  ±2.0 ±5.0 ±5.8 ± 1.00 ± 0.10 ± 0.16 
 
 0.2 28.5** 29.6* 21.5 4.83** 0.97 1.51 
  ±0.6 ±3.2 ±4.7 ±0.52 ±0.10 ±0.16 
 
 0.334 53.2** 18.0** 22.7 3.01** 1.01 1.57 
  ±2.7 ±3.6 ±1.6 ±0.41 ±0.14 ±0.21 
 
 
Ka: min-1 X 10-3; CLa,app: mL min-1 X 10-3; Papp: cm min-1 X 10-3.   Each value is the mean 
± s.e. of four experiments.   Significantly different from the result at 0.1 mL (*p < 





Table 2.  Recovery in 6 h and pharmacokinetic parameters of phenol red at a dose 
of 1 mg after application to rat liver surface under various conditions. 
 
 
 Area Volume  Recovery (% of dose)  Ka CLa,app Papp
 (cm2) (mL) Glass cell Bile Urine    
 
 
 0.28 0.1 32.6** 23.9** 35.8 4.91** 0.49** 1.74 
   ±2.0 ±3.4 ±2.3 ±0.57 ±0.06 ±0.20 
 
 0.64 0.1 8.2 50.7 29.3 9.20 0.92 1.44 
   ±2.0 ±5.0 ±5.8 ±1.00 ±0.10 ±0.16 
 
 0.64 0.334 53.2 18.0 22.7 3.01 0.97 1.57 
   ±2.7 ±3.6 ±1.6 ±0.41 ±0.10 ±0.21 
 
 1.54 0.334 17.6** 33.0 33.4 7.88** 2.63** 1.71 
   ±1.1 ±5.6 ±6.3 ±0.77 ±0.26 ±0.17 
 
 
Ka: min-1 X 10-3; CLa,app: mL min-1 X 10-3; Papp: cm min-1 X 10-3.   Each value is the mean 





Table 3.  Recovery in 6 h and pharmacokinetic parameters of phenol red at a dose 
of 1 mg in three volumes after intraperitoneal administration to rat liver surface. 
 
 
 Volume  Recovery (% of dose)  Ka CLa,app Papp
 (mL) Bile Urine    
 
 
 0.2 51.3 26.0 3.71 0.74 0.45 
  ±9.6 ±7.9 ±0.57 ±0.11 ±0.07 
 
 1 43.6 36.2 2.96 2.96* 0.61 
  ±8.0 ±9.8 ±0.72 ±0.72 ±0.15 
 
 5 57.7 20.9 1.34 ** 6.75** 0.48 
  ±2.3 ±7.1 ±0.25 ±1.25 ±0.09 
 
 
Ka: min-1 X 10-2; CLa,app: mL min-1 X 10-2; Papp: cm min-1 X 10-2.   Each value is the mean 
± S.E. of four experiments.   Significantly different from the result at 0.2 mL (*p < 
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